PB23

ICD-11 MMS 2026-01

Unintentional exposure to or harmful effects of cannabinoids or hallucinogens

Index terms

  • Unintentional exposure to or harmful effects of cannabinoids or hallucinogens
  • accidental overdose of cannabinoids or hallucinogens
  • accidental poisoning by cannabinoids or hallucinogens
Show allHide
  • cannabinoids or hallucinogens taken in error
  • Unintentional exposure to or harmful effects of cannabis
  • harmful effect of natural cannabis
  • harmful effect of phytocannabinoids
  • Unintentional exposure to or harmful effects of synthetic cannabinoids
  • Unintentional exposure to or harmful effects of lysergide
  • unintentional harmful effect of LSD
  • Unintentional exposure to or harmful effects of unspecified psychodysleptics
  • Unintentional harmful effect of hallucinogens
  • Unintentional exposure to or harmful effects of other psychodysleptics
  • Accidental poisoning by and exposure to narcotics and psychodysleptics or hallucinogens, not elsewhere classified
  • Accidental cannabis poisoning
  • accidental overdose of cannabis
  • Accidental cocaine poisoning
  • accidental overdose of cocaine
  • Accidental mescaline poisoning
  • accidental overdose of mescaline
  • Accidental nabilone poisoning
  • accidental overdose of nabilone
  • Accidental psilocybin poisoning
  • accidental overdose of psilocybin

Inclusions

  • accidental overdose of cannabinoids or hallucinogens

Excludes

  • http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm in therapeutic use

Sibling codes

  • PB20 – Unintentional exposure to or harmful effects of opioids or related analgesics
  • PB21 – Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants
  • PB22 – Unintentional exposure to or harmful effects of psychostimulants
  • PB24 – Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
  • PB25 – Unintentional exposure to or harmful effects of antidepressants
  • PB26 – Unintentional exposure to or harmful effects of antipsychotics
  • PB27 – Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
  • PB28 – Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance
  • PB29 – Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances

Foundation entity

Unintentional exposure to or harmful effects of cannabinoids or hallucinogens – http://id.who.int/icd/entity/1800966096

Allowed postcoordination axes

Part of: 23: External causes of morbidity or mortality